7-azole substituted 2-aminoquinazoline inhibitors of hpk1
AssigneeMerck Sharp & Dohme Corp.
InventorsJoanna L. Chen, Peter H. Fuller, Joey L. Methot, Elsie C. Yu
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck Sharp & Dohme Corp.
InventorsJoanna L. Chen, Peter H. Fuller, Joey L. Methot, Elsie C. Yu
Estimating the term…
Compounds of the following formula (I); or the pharmaceutically acceptable salts thereof, are inhibitors of haematopoietic progenitor kinase 1 (HPK1) useful in the treatment of diseases or disorders associated with HPK1. Also disclosed herein are uses of these compounds in the potential treatment or prevention of an HPK1-associated disease or disorder. Also disclosed herein are compositions comprising one or more of the compounds. Further disclosed herein are uses of these compositions in the potential prevention or treatment of an HPK1-associated disease or disorder.
A compound of the formula (I):
A compound which is selected from the group consisting of:
(canceled)
(canceled)
Dependencies are inferred from the claim text.